secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2022-11-15T23:59:59+00:00
Accession:  0001628280-22-029935
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute announces Q3 2022 results and FY2022 guidance via slide deck
-------------------------------------------------------------------------------

- Slide presentation includes financial results for three and nine months ended Sept 30, 2022.
- Company provided updated business guidance for the year ending Dec 31, 2022.
- Presentation issued on Nov 15, 2022; common stock (TOI) and warrants (TOIIW) traded on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/0001628280-22-029935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/toi-20221115.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-029935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer